Praxis Precision Medicines, Inc. Profile Avatar - Palmy Investing

Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA rec…

Biotechnology
US, Boston [HQ]

News

Theses · Events · Sentiments
End of PRAX's Analysis
CIK: 1689548 CUSIP: 74006W108 ISIN: US74006W2070 LEI: - UEI: -
Secondary Listings
PRAX has no secondary listings inside our databases.